Poglajen, G., Ksela, J., Frljak, S., Zemljic, G., Boznar Alic, E., Cerar, A., & Vrtovec, B. (2019). Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure. Dis Markers.
Citação norma ChicagoPoglajen, Gregor, Jus Ksela, Sabina Frljak, Gregor Zemljic, Elizabeta Boznar Alic, Andraz Cerar, and Bojan Vrtovec. "Favorable Response to CD34+ Cell Therapy Is Associated With a Decrease of Galectin-3 Levels in Patients With Chronic Heart Failure." Dis Markers 2019.
Deismireacht MLAPoglajen, Gregor, et al. "Favorable Response to CD34+ Cell Therapy Is Associated With a Decrease of Galectin-3 Levels in Patients With Chronic Heart Failure." Dis Markers 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.